Back

Remnant cholesterol predicts major cardiovascular events in coronary artery disease patients with NAFLD

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Lipoproteins and cardiovascular risk Lipids ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speakers

Photo
Professor Heinz Drexel

Vorarlberg Institute for Vascular Investigation and Treatment, Feldkirch (Austria)

Photo
Doctor Arthur Mader

VIVIT Institute, Feldkirch (Austria)

7 More presentations in this session

Presentation thumbnail
Sex-specific guideline target value attainment and prognostic value of low-density lipoprotein cholesterol in tertiary care
Ms K. Rumora (Basel, CH)
Abstract Slides Video
Presentation thumbnail
Circulating Amyloid beta 1-40 is independently associated with statin treatment and LDL cholesterol reduction: a prospective cohort study
Doctor E. Aivalioti (Athens, GR)
Abstract Slides Video
Presentation thumbnail
Factors influencing low-density-lipoprotein cholesterol after acute coronary syndrome and effectiveness of intensive teleconsultation monitoring, the teleobjectif cohort study
Doctor A. Lemaitre (Caen, FR)
Abstract Slides Video
Presentation thumbnail
Remnant cholesterol, clinical characteristics and mortality in 41.767 patients from LIPIDOGRAM 2004-2015 studies - the factor analysis for mixed data cluster analysis
Professor M. Banach (Lodz, PL)
Abstract Slides Video
Presentation thumbnail
Relationship of cumulative low-density lipoprotein cholesterol with atherosclerosis
Doctor T. Yamaji (Hiroshima, JP)
Abstract Slides Video

Access the full session

Session thumbnail
Lipoproteins and cardiovascular risk

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Remnant cholesterol is a predictor for all-cause mortality in coronary artery disease patients independent of the total ApoB-particle count
thumbnail
Congress Presentation
Remnant cholesterol and risk of coronary heart disease beyond LDL-cholesterol and HDL-cholesterol: a population-based prospective cohort study
thumbnail
Congress Presentation
Remnant cholesterol lowering in cardiovascular disease risk reduction in statin trials: meta-regression analyses

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources